Natural measles causes prolonged suppression of interleukin-12 production
- PMID: 11398102
- DOI: 10.1086/321009
Natural measles causes prolonged suppression of interleukin-12 production
Abstract
Among vaccine-preventable diseases, measles is the preeminent killer of children worldwide. Infection with measles virus (MV) is associated with prolonged suppression of cell-mediated immune responses, a phenomenon that is thought to underlie the susceptibility to secondary infections that accounts for most measles-related mortality. Interleukin (IL)-12 is critical for the orchestration of cellular immunity. MV specifically ablates IL-12 production by monocyte/macrophages in vitro through binding to CD46, a complement regulatory protein that is an MV receptor. To address the effect of MV on IL-12 responses in vivo, cytokine production was examined in Gambian patients with measles. IL-12 production by peripheral blood monocytes from such patients is markedly suppressed, which provides a unifying mechanism for many of the immunologic abnormalities associated with measles. This suppression is prolonged, with significant, stimulus-specific inhibition of IL-12 production demonstrable months after recovery from acute infection. However, despite this suppression, IL-12 responsiveness remains intact.
Similar articles
-
IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants.J Immunol. 1999 May 1;162(9):5569-75. J Immunol. 1999. PMID: 10228039
-
Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses.J Infect Dis. 2003 Nov 15;188(10):1553-61. doi: 10.1086/379250. Epub 2003 Oct 28. J Infect Dis. 2003. PMID: 14624382
-
Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles.J Infect Dis. 2002 Jan 1;185(1):13-9. doi: 10.1086/338009. Epub 2001 Dec 14. J Infect Dis. 2002. PMID: 11756976
-
Measles: immune suppression and immune responses.Int J Biochem Cell Biol. 2004 Aug;36(8):1380-5. doi: 10.1016/j.biocel.2004.01.019. Int J Biochem Cell Biol. 2004. PMID: 15147716 Review.
-
Measles virus: immunomodulation and cell tropism as pathogenicity determinants.Med Microbiol Immunol. 2002 Oct;191(2):83-7. doi: 10.1007/s00430-002-0121-6. Epub 2002 Aug 17. Med Microbiol Immunol. 2002. PMID: 12410346 Review.
Cited by
-
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling.J Virol. 2002 Sep;76(17):8729-36. doi: 10.1128/jvi.76.17.8729-8736.2002. J Virol. 2002. PMID: 12163593 Free PMC article.
-
Emerging diseases: measles.J Neurovirol. 2005 Oct;11(5):447-54. doi: 10.1080/13550280591002441. J Neurovirol. 2005. PMID: 16287686 Review.
-
Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression.J Virol. 2004 Nov;78(21):11952-61. doi: 10.1128/JVI.78.21.11952-11961.2004. J Virol. 2004. PMID: 15479835 Free PMC article.
-
Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients.J Neurovirol. 2016 Oct;22(5):661-665. doi: 10.1007/s13365-016-0442-7. Epub 2016 Apr 21. J Neurovirol. 2016. PMID: 27103395
-
Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.J Neurovirol. 2007 Oct;13(5):410-5. doi: 10.1080/13550280701455383. J Neurovirol. 2007. PMID: 17994425
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical